Phase 3 double-blind placebo-controlled randomized trial of Z-100 in patients with radiation therapy for cervical cancer.

Trial Profile

Phase 3 double-blind placebo-controlled randomized trial of Z-100 in patients with radiation therapy for cervical cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 13 May 2016

At a glance

  • Drugs Z 100 (Primary)
  • Indications Cervical cancer
  • Focus Therapeutic Use
  • Sponsors Zeria
  • Most Recent Events

    • 31 May 2013 Primary endpoint 'Overall-survival-rate' has not been met.
    • 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 19 Jan 2012 Planned end date changed from 1 Jun 2010 to 1 Mar 2013 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top